Core Viewpoint - Phaos Technology Holdings has successfully closed an offering of 405,500 class A ordinary shares, raising gross proceeds of US$1.62 million, following the full exercise of the over-allotment option by Network 1 Financial Securities [1][2]. Group 1: Offering Details - The offering was conducted under the Company's registration statement on Form F-1, which became effective on November 11, 2025 [3]. - A final prospectus related to the offering was filed with the SEC on November 13, 2025, and is available on the SEC's website [3]. Group 2: Company Overview - Phaos Technology Holdings is an advanced microscopy technology company based in Singapore, focusing on delivering innovative microscopy products and software solutions powered by artificial intelligence for various sectors, including manufacturing, biomedical, and research [5].

Core Viewpoint - Phaos Technology Holdings (Cayman) Limited has announced the pricing of its initial public offering (IPO) of 3,600,090 class A ordinary shares at a price of US$4.00 per share, aiming to raise a total of $10.8 million in gross proceeds from the offering [1][2]. Offering Details - The company is offering 2,700,000 class A ordinary shares, which will generate gross proceeds of $10,800,000 before deducting underwriting discounts and expenses [1]. - Certain selling shareholders are offering an additional 900,090 class A ordinary shares, from which the company will not receive any proceeds [1]. - The underwriters have been granted a 45-day option to purchase up to an additional 405,000 class A ordinary shares to cover over-allotments, representing 15% of the shares sold in the offering [2]. Trading Information - The shares are expected to begin trading on the NYSE American under the ticker symbol "POAS" on November 13, 2025, with the offering expected to close on November 14, 2025, subject to customary closing conditions [3]. Legal and Regulatory Framework - The offering is being conducted under the company's registration statement on Form F-1, which was declared effective by the U.S. Securities and Exchange Commission (SEC) on July 31, 2025 [5]. - The company has filed post-effective amendments to the F-1 registration statement, with the latest amendment becoming effective on November 11, 2025 [5]. Company Overview - Phaos Technology Holdings is a leader in advanced microscopy technology, focusing on delivering innovative microscopy products and software solutions powered by artificial intelligence for various sectors, including manufacturing, biomedical, and research [7].